We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Requires More Studies for New Drugs with Potential for Abuse
FDA Requires More Studies for New Drugs with Potential for Abuse
Sponsors pursuing approval of new drugs that demonstrate central nervous system activity should expect to perform thorough assessments of any potential for abuse, and be aware of specific NDA requirements.